CUSABIO has succeed in producing Nanobodies and recombinant antibodies specific for COVID-19 after repetitive refinement and verification.
Attached is the catalog including all 11 CUSABIO antibodies specific for COV-19, the discount is still 50% off from the list price.
Please kindly let me introduce our SARS-CoV-2 Spike RBD Nanobody for you briefly, as far as we know, our competitors have not produced any Nanobody specific for COVID-19, so our SARS-CoV-2 Spike RBD Nanobody (catalog number #CSB-RA33245A2GMY) is really very competitive.
Our SARS-CoV-2 Spike RBD Nanobody had been applied in ELISA, GICA (Colloidal Gold Immunochromatography Assay) and Neutralization successfully, please kindly click above link for detailed information.
You know the Nanobodies are very small in size, with a molecular weight of only 12-15 kDa, and Nanobodies have good biophysical properties, so they can be administered by inhalation, which makes Nanobodies particularly suitable for the treatment of respiratory diseases. Therefore, the SARS-CoV-2 Spike RBD Nanobody plays a very important role and has significance in the research of novel Coronavirus.
The attached COVID-19 antibodies are very popular among our customers, and i sincerely hope your team could push these antibodies to contribute some efforts on the research of the outbreak.
